Quarterly ResultMay 15, 2026, 07:42 AM
Rapid Micro Biosystems Q1 Net Loss $(14.28)M; Revenue $8.0M
AI Summary
Rapid Micro Biosystems reported a net loss of $(14.28) million for Q1 2026, a significant increase from $(11.26) million in Q1 2025. Total revenue grew to $8.00 million from $7.21 million year-over-year, driven by product revenue growth but offset by a decline in service revenue. The company also experienced a substantial increase in net cash used in operating activities, reaching $(15.06) million, and a decrease in cash and cash equivalents to $13.82 million.
Key Highlights
- Q1 2026 net loss increased to $(14.28) million from $(11.26) million in Q1 2025.
- Total revenue for Q1 2026 rose 11.1% to $8.00 million from $7.21 million year-over-year.
- Product revenue increased 36.0% to $5.58 million, while service revenue decreased 21.9% to $2.42 million.
- Gross margin declined to $0.37 million in Q1 2026 from $0.40 million in Q1 2025.
- Net cash used in operating activities increased to $(15.06) million from $(9.07) million.
- Cash and cash equivalents decreased to $13.82 million as of March 31, 2026.
- Customer A and Customer D represented 11.9% and 14.3% of Q1 2026 total revenue, respectively.
Price Impact
More from RPID